Clinigen Group PLC (LSE:CLIN) - Share price


Stock Report

Clinigen Group PLC CLIN

Last Price
GBX742.50

Day Change
5.00|0.68%

As of 26/02/2020
14:11:39 GMT | GBX
Minimum 15 Minutes Delay.

Last Close737.50p
Day Range740.00 - 772.00
Mkt Cap979.80Mil
52-Wk Range733.00 - 1,069.00
Yield %0.91
ISINGB00B89J2419
Volume792,950
P/E72.46
P/S0.02
P/CF0.14

Share Price

Total Returns 25/02/2020

 Chg (%)  
More ...
Clinigen Group PLC-24.78 
FTSE 100 TR GBP-7.15
 
Financials
201720182019
More ...
Income Statement
Turnover302.30381.20456.90
Operating Profit44.8049.7058.00
Net Profit3.8027.405.20
Reported EPS3.2022.504.00
Balance Sheet
Current Assets111.40153.50231.30
Non Current Assets348.10513.60834.80
Total Assets459.50667.101,066.10
Current Liabilities134.80113.80243.40
Total Liabilities---
Total Equity249.10349.50438.40
Cash Flow
Operating Cash Flow53.0060.2081.90
Net Change in Cash-0.508.8046.80

Regulatory News

DateAuthor Headline
18/10/2017Samuel Meakin Why Smaller Companies Funds Have Outperformed
The average UK smaller companies fund has comfortably outperformed the FTSE Small Cap and Numis Smaller Companies indices in 2017 so far
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/09/2019PurchaseMr. Nicholas Patrick Keher893.003,90034,827.00

Company Profile

Clinigen Group PLC is engaged in pharmaceutical and services business. It provides its services to patients, the medical community and the healthcare industry.

Sector

Medical Distribution

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All-Share

Next Event 18/09/2020

Final Results
Ratios
Comp
More ...
PER (E)242.25
Div Yld (E)0.69
PEG (E)0.00
ROCE2.42
Op Mrgn0.13
EPS Grwth-0.12
Dividends
PreviousLatest
More ...
Record Date08/11/1920/03/20
Ex-Div07/11/1919/03/20
Paid29/11/1917/04/20
Amnt4.752.15
Directors
More ...
Non-Executive DirectorMs Anne Philomena Hyland
Non-Executive Director, ChairmanMr. Peter Vance Allen
Non-Executive DirectorMr. Ian James Nicholson
Non-Executive DirectorMr. John Hartup
Executive Director, Chief Executive OfficerShaun Edward Chilton
Executive Director, Chief Financial OfficerMr. Nicholas Patrick Keher
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.